Lipocine Interest Expense from 2010 to 2024
| LPCN Stock | USD 4.44 0.36 7.50% |
Interest Expense | First Reported 2011-12-31 | Previous Quarter 0.0 | Current Value 0.0 | Quarterly Volatility 221.4 K |
Check Lipocine financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Lipocine main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 5.8 M or Total Revenue of 104.5 K, as well as many exotic indicators such as Price To Sales Ratio of 140, Dividend Yield of 0.0048 or PTB Ratio of 0.96. Lipocine financial statements analysis is a perfect complement when working with Lipocine Valuation or Volatility modules.
Lipocine | Interest Expense |
Latest Lipocine's Interest Expense Growth Pattern
Below is the plot of the Interest Expense of Lipocine over the last few years. It is the cost incurred by an entity for borrowed funds, including loans, bonds, or lines of credit. Lipocine's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Lipocine's overall financial position and show how it may be relating to other accounts over time.
| Interest Expense | 10 Years Trend |
|
Interest Expense |
| Timeline |
Lipocine Interest Expense Regression Statistics
| Arithmetic Mean | 64,017 | |
| Geometric Mean | 0.00 | |
| Coefficient Of Variation | 207.86 | |
| Mean Deviation | 98,815 | |
| Median | 0.00 | |
| Standard Deviation | 133,064 | |
| Sample Variance | 17.7B | |
| Range | 386.6K | |
| R-Value | 0.34 | |
| Mean Square Error | 16.9B | |
| R-Squared | 0.11 | |
| Significance | 0.22 | |
| Slope | 9,982 | |
| Total Sum of Squares | 247.9B |
Lipocine Interest Expense History
About Lipocine Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Lipocine income statement, its balance sheet, and the statement of cash flows. Lipocine investors use historical funamental indicators, such as Lipocine's Interest Expense, to determine how well the company is positioned to perform in the future. Although Lipocine investors may use each financial statement separately, they are all related. The changes in Lipocine's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Lipocine's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Lipocine Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Lipocine. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Interest Expense | 27.1 K | 0.0 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Lipocine Correlation against competitors. To learn how to invest in Lipocine Stock, please use our How to Invest in Lipocine guide.Note that the Lipocine information on this page should be used as a complementary analysis to other Lipocine's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Complementary Tools for Lipocine Stock analysis
When running Lipocine's price analysis, check to measure Lipocine's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Lipocine is operating at the current time. Most of Lipocine's value examination focuses on studying past and present price action to predict the probability of Lipocine's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Lipocine's price. Additionally, you may evaluate how the addition of Lipocine to your portfolios can decrease your overall portfolio volatility.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |
Is Lipocine's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Lipocine. If investors know Lipocine will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Lipocine listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.14) | Revenue Per Share (0.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.37) | Return On Equity (0.58) |
The market value of Lipocine is measured differently than its book value, which is the value of Lipocine that is recorded on the company's balance sheet. Investors also form their own opinion of Lipocine's value that differs from its market value or its book value, called intrinsic value, which is Lipocine's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Lipocine's market value can be influenced by many factors that don't directly affect Lipocine's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Lipocine's value and its price as these two are different measures arrived at by different means. Investors typically determine if Lipocine is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Lipocine's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.